8 - Anti-Parkinsons Drugs Flashcards
Neurodegenerative Disorders: Parkinson’s/Huntington’s Disease Defined (2)
Loss of neurons from structures of basal ganglia
Results in abnormalities in the control of movement
Neurodegenerative Disorders: Alzheimer’s Disease Defined (2)
Loss of hippocampal and cortical neurons
Leads to impairment of memory and cognitive ability
Neurodegenerative Disorders: ALS Defined (2)
Degeneration of spinal, bulbar, and cortical motor neurons
Muscular weakness
Parkinson’s Disease Defined (2)
Neuronal loss in the substantia nigra
Decrease dopamine the nigrostriatal pathway
Parkinson’s Disease: Less what and more of what?
Less dopamine and more acetylcholine
Parkinson’s Disease: Since there’s dopamine, what classes of drugs can be used? (3)
Dopamine agonists
Drugs that inhibit breakdown of dopamine
Anti-muscarinics to inhibit ACH
Parkinson’s Disease: Causes - Drugs
Typical Antipsychotics (Block D2 Receptors) such as Haloperidol
Parkinson’s Disease: Causes - Genes (2)
Alpha-synuclein
Parkin
Parkinson’s Disease: Cause - Chemical (2)
MPP
Oxidative stress (free radicals)
Parkinson’s Disease: Symptoms (4)
- Resting tremor
- Muscular rigidity
- Bradykinesia
- Postural balance impairment
Parkinson’s Disease Drugs: “On Time”
When medication is having a benefit and your symptoms are well controlled (e.g. levodopa)
Parkinson’s Disease Drugs: “Off Time”
Medication not working and symptoms return
Parkinson’s Disease Drugs: “Wearing-off”
Improvement gained from a dose of your medication gradually fades and doesn’t last until next dose (due to short half-life)
Parkinson’s Disease Drugs: “Delayed On”
Increased delay after taking your medication before you feel the benefits
Parkinson’s Disease Drugs: “On-Off” Phenomenon
Sudden, sometimes unpredictable changes in symptoms varying between mobility and immobility
Parkinson’s Disease Drugs: “Freezing episodes” and Rx
Sudden, brief periods of immobility; feet feel like they’re glued to floor
Rx: APOmorphine (very potent opioid dopamine agonist)
Parkinson’s Disease Drugs: Dopamine Precursors (1)
Levodopa
Parkinson’s Disease Drugs: Peripheral Decarboxylase Inhibitors (1)
Carbidopa
Parkinson’s Disease Drugs: Dopamine Receptor Agonists (CNS) (4)
Pramipexole
Ropinirole
Bromocriptine
Apomorphine
Parkinson’s Disease Drugs: Monoamine Oxidase B Inhibitors (2)
Selegiline
Rasagiline
Parkinson’s Disease Drugs: COMT Inhibitors (2)
Entacapone
Tolcapone
Parkinson’s Disease Drugs: Dopamine Facilitators (Antiviral) (1)
Amantadine
Parkinson’s Disease Drugs: CNS Anticholinergic Agents (2)
Benztropine
Trihexyphenidyl
Excess ACH causes what?
Delirium/psychosis
Decreased ACH causes what?
Alzheimer’s
Excess Dopamine in CNS causes what?
Psychosis
Decreased Dopamine causes what?
Parkinsons
Excess GABA causes what?
More sedation, drowsiness, and depression
Decreased GABA causes what?
Spasms
Carbidopa inhibits what but can’t?
Inhibits AAAD/Dopa decarboxylase
Can’t cross BBB
Pyridoxine (B6) is a co-factor of what, which is why you can’t use it with what drug?
Co-factor of AAAD/Dopa decarboxylase
Can’t use it with Levodopa (B6 increases metabolism of Levodopa
Levodopa Outside Brain: What drugs inhibit the enzymes that convert levodopa to other things? (2)
Carbidopa (inhibits AAAD)
Entacapone - doesn’t cross BBB (Inhibits conversion to 3-O-Methyldopa)
Levodopa Inside Brain: Levodopa doesn’t get converted to 3-O-Methyldopa by what drug? And what are its side effects
Tolcapone (similar to entacapone and crosses BBB)
Causes liver toxicity
Levodopa Inside Brain:: Dopamine doesn’t get broken down by what drug?
Selegline
Parkinson’s Drugs: What drug binds to D1 and D2 Receptors (1)
Bromocriptine
Parkinson’s Drugs: Levodopa/L-Dopa Defined (3)
Crosses BBB
Prodrug converted to dopamine by AAAD
Stimulates D2 receptors
Parkinson’s Drugs: L-Dopa is given in combo with drug?
Carbidopa: dopa decarboxylase inhibitor –> peripheral metabolism of levodopa is reduced
Parkinson’s Drugs: Levodopa Clinical Use (2)
Used in the first few years before tolerance develops
Most effective on BRADYKINESIA and RIGIDITY
Parkinson’s Drugs: Levodopa Pharmacologic Effects (3)
Tolerance to both beneficial and adverse effects occurs with time
Most effective in the first 2-5 years of treatment
After 5 years –> dose-related dyskinesia, inadequate response or toxicity
Parkinson’s Drugs: L-Dopa + Cabidopa name and particularly effective in relieving what?
Sinemet
Relieving bradykinesia
Parkinson’s Drugs: L-Dopa Adverse Effects - GIT (3)
80% of patients: anorexia, NV; with tolerance over time (Rx trimethobenzamide)
Avoid phenothiazine emetics (chlorpromazine, metaclopramide)
Effects become less frequent with L-Dopa + Carbidopa
Parkinson’s Drugs: L-Dopa Adverse Effects - Cardiovascular (3)
Cardiac Arrhythmias
Tachycardia
Postural hypotension
Parkinson’s Drugs: L-Dopa Adverse Effects - Behavioral Effects (8)
Depression, Anxiety, Agitation, Insomnia, Confusion, Hallucinations, Nightmares, and Euphoria
Parkinson’s Drugs: L-Dopa Adverse Effects - Dyskinesias
Choreoathetosis of the face and distal extremities
Parkinson’s Drugs: L-Dopa Adverse Effects - Fluctuations in Response (2)
Wearing off reactions or end of dose akinesia: rigidity and akinesia return rapidly at the end of the dosing interval
On-off phenomenon: off-periods of marked akinesia alternate with on-periods of improved mobility
Parkinson’s Drugs: L-Dopa Adverse Effects - Miscellaneous (2)
Mydriasis that may precipitate acute glaucoma, gout, and taste abnormalities
Brownish discoloration of saliva, urine, or vaginal secretions
Parkinson’s Drugs: L-Dopa: Never give L-dopa with what drugs (3)
- Non-Selective MAO inhibitors (e.g. phenelzine) –> may lead to hypertensive crisis and hyperpyrexia
- Pyridoxine (B6) –> promotes peripheral conversion of L-dopa to dopamine and reduces L-dopa therapeutic effect
- Phenothiazines and Butyrophenones –> antagonize by blocking D2 receptors
Parkinson’s Drugs: L-Dopa Contraindications (4)
- Psychotic patients (worsens)
- Angle closure glaucoma (mydriasis)
- Peptic ulcer
- Melanoma & skin lesions
Parkinson’s Drugs: Carbidopa is an inhibitor of and is combined with what drug for what? (2)
Inhibitor of dopa decarboxylase
Combined with levodopa to reduce peripheral conversion of levodopa to dopamine
Parkinson’s Drugs: Action of MPTP causes? MPTP is converted into MPP+ by what enzyme? What drug inhibits this enzyme?
Causes irreversible destruction of nigrostriatal dopaminergic neurons in various species
MPTP converted into MPP+ by MAO-B enzyme
Selegiline inhibits MAO-B
Parkinson’s Drugs: MPP+ is taken up by, selective in, and inhibits what, producing? (3)
Taken up by the dopaminergic neurons
Selective in destroying nigrostriatal neurons
Inhibits mitochondrial reactions, producing oxidative stress
Parkinson’s Drugs: Dopamine Receptor Agonists - Bromocriptine (2)
Ergot D2 agonist
Long term use associated with cardiac valve fibrosis
Parkinson’s Drugs: Dopamine Receptor Agonists - Pramipexole (3)
Preferential affinity for the D3 family of receptors
Used in patients with advanced Parkinson’s disease
Neuroprotective - scavenge hydrogen peroxide
Parkinson’s Drugs: Dopamine Receptor Agonists - Ropinirole (1)
Relatively pure D2 receptor agonist
Parkinson’s Drugs: Apomorphine is used for?
Freezing episodes (unable to move)
Parkinson’s Drugs: Apomorphine Defined (2)
Potent dopamine agonist
Provide quick relief (rescue) of Off-periods/freezing episodes of akinesia in patients on dopaminergic therapy
Parkinson’s Drugs: Apomorphine Adverse Effects (2)
Nausea and Vomiting (pre-treat with Trimethobenzamide)
Dyskinesias (Rx benzotropine (anti-muscarinic))
Parkinson’s Drugs - MOA Oxidase B Inhibitors: Selegiline Defined
A selective irreversible inhibitor of MAO- B at normal doses, increase dopamine in basal ganglia
Parkinson’s Drugs - MOA Oxidase B Inhibitors: Selegiline (4)
Enhances and prolongs the antiparkinsonism effect of levodopa
Reduce mild on-off or wearing-off phenomena.
Adjunctive therapy for patients with a declining or fluctuating response to levodopa
Neuroprotective effect (decreases free radicals), inhibits progression of disease
Parkinson’s Drugs - MOA Oxidase B Inhibitors: Rasagiline Defined and Adverse Effects (2 overall)
It is more potent than selegiline in
In preventing MPTP induced parkinsonism
Adverse effect: May enhance adverse effects of levodopa
Parkinson’s Drugs: COMT Inhibitors - Tolcapone and Entacopone (3)
Also prolong action of levodopa by diminishing its peripheral metabolism
Levodopa clearance is decreased and relative bioavailability of levodopa is increased
Helpful in patients receiving levodopa who have developed response fluctuations
Parkinson’s Drugs: COMT Inhibitors - Main Adverse Effect
Orange discoloration of the urine
Parkinson’s Drugs: COMT Inhibitors - Tolcapone Adverse Effect
May cause an increase in liver enzyme levels and fulminant hepatic failure
Parkinson’s Drugs: Amantadine is an?
Antiviral agent that’s a prophylaxis of influenza A2
Parkinson’s Drugs: Amantadine MOA (1) and Use (1)
May potentiate dopaminergic function by influencing the synthesis, release, or re-uptake of dopamine
It has been used alone to treat early PD and as an adjunct in later stages
Parkinson’s Drugs: Amantadine Adverse Effects (1)
Livedo reticularis
Parkinson’s Drugs: Muscarinic Receptor Antagonists: Benztropine, Trihexyphenidyl and Diphenhydramine - Treat drug induced dyskinesia but has no effect on what symptom of Parkinson’s?
Improve the tremor and rigidity of parkinsonism but have little effect on bradykinesia.
Used in combo
Parkinson’s Drugs: Muscarinic Receptor Antagonists: Benztropine, Trihexyphenidyl and Diphenhydramine - Adverse Effects
Dry mouth, agitation, confusion, constipation, dry mouth, memory loss, urianry retention and tachycardia
Parkinson’s Drugs: Vaccine
4 injections that will hopefully stimlate an immune system response against alpha-synuclein (abs will attack brain proteins and clear them)
Parkinson’s Drugs: Other - Surgical Procedures (3)
Thalamotomy
Deep brain stimulation
Transplantation of dopaminergic tissue
Parkinson’s Drugs: Other - Gene Therapy (1)
Adeno-associated virus type 2 as vector glutamic acid decarboxylase (GAD) gene
Drugs for restless legs syndrome (5)
Pramipexole
Ropinrole
Diazepam
Gabapentin
Opiates
Wilson’s Disease defined
Decreased serum copper and ceruloplasmin
Drugs for Wilson’s Disease (3) and do what?
Penicillamine, Trietntine
Chelates copper, tetraothiomolymbdate, and zinc
Drugs for ALS (4)
Baclofen (GABA agonist)
Tizanidine (alpha 2 agonist)
Gabapentin
Riluzole (inhibits sodium channels and decreases glutamate)
Drugs for MS (6)
Interferons
Natalizumab
Mitoxantrone
Glatiramer
Fingolimod
Dalfampridine
Alzheimer’s Disease Gross
Marked atrophy of the cerebral cortex and loss of cortical and subcortical neurons
Alzheimer’s Drugs: Acetylcholinesterase Inhibitors (4)
Rivastigmine
Donepezil
Gallanatamine
Tacrine
Alzheimer’s Drugs: Glutamate receptors antagonist (1)
Mementaine
Huntington’s Disease: NT Levels
Decrease GABA and ACH
Increase dopamine
Huntington’s Disease: Drugs (3)
Tetrabenzine and Reserpine - inhibits VMAT, and limits dopamine vesicle and packaging and release
Haloperidol